PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade.

Hirsch, Laure; Zitvogel, Laurence; Eggermont, Alexander; Marabelle, Aurelien

Hirsch, Laure; Zitvogel, Laurence; Eggermont, Alexander; Marabelle, Aurelien.

Affiliation

Hirsch L; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
Zitvogel L; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Eggermont A; Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
Marabelle A; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France. aurelien.marabelle@gustaveroussy.fr.

Br J Cancer ; 120(1): 3-5, 2019 01.

Article in En | MEDLINE | ID: mdl-30413824

Subject(s)

B7-H1 Antigen/immunology; Immunotherapy; Neoplasms/therapy; Programmed Cell Death 1 Receptor/immunology; Antibodies, Monoclonal/immunology; Antibodies, Monoclonal/therapeutic use; B7-H1 Antigen/antagonists & inhibitors; Clinical Trials as Topic; Humans; Neoplasms/classification; Neoplasms/genetics; Neoplasms/immunology; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Signal Transduction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor / Immunotherapy / Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2019 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google